CA2274116A1 - Use, of an inhibitor of thioredoxin, for inhibiting tumor growth - Google Patents
Use, of an inhibitor of thioredoxin, for inhibiting tumor growth Download PDFInfo
- Publication number
- CA2274116A1 CA2274116A1 CA002274116A CA2274116A CA2274116A1 CA 2274116 A1 CA2274116 A1 CA 2274116A1 CA 002274116 A CA002274116 A CA 002274116A CA 2274116 A CA2274116 A CA 2274116A CA 2274116 A1 CA2274116 A1 CA 2274116A1
- Authority
- CA
- Canada
- Prior art keywords
- thioredoxin
- inhibitor
- tumor growth
- inhibiting tumor
- agents
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention re]ates to the use of thioredoxin as, inter alia, a cell growth stimulator, as well as a screen for agents that are useful in reducing or preventing thioredoxin-associated apoptosis inhibition and agents that are useful in inhibiting thioredoxin stimulated cell growth.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3199596P | 1996-12-06 | 1996-12-06 | |
US60/031,995 | 1996-12-06 | ||
PCT/US1997/022292 WO1998024472A1 (en) | 1996-12-06 | 1997-12-05 | Uses of thioredoxin |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2274116A1 true CA2274116A1 (en) | 1998-06-11 |
CA2274116C CA2274116C (en) | 2009-05-05 |
Family
ID=21862543
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002274116A Expired - Fee Related CA2274116C (en) | 1996-12-06 | 1997-12-05 | Use, of an inhibitor of thioredoxin, for inhibiting tumor growth |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP0946192A1 (en) |
CA (1) | CA2274116C (en) |
WO (1) | WO1998024472A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6552060B1 (en) | 1997-08-11 | 2003-04-22 | Prolx Pharmaceuticals, Inc. | Asymmetric disulfides and methods of using same |
US6372772B1 (en) | 1997-08-01 | 2002-04-16 | Prolx Pharmaceuticals Corporation | Inhibitors of redox signaling and methods of using same |
IL137177A0 (en) | 1998-01-30 | 2001-07-24 | Genesense Technologies Inc | Oligonucleotide sequences complementary to thioredoxin or thioredoxin reductase genes and methods of using same to modulate cell growth |
AU2003263795A1 (en) * | 2002-08-02 | 2004-02-23 | University Of Rochester | Thioredoxin mutants and uses thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE8903003D0 (en) * | 1989-09-12 | 1989-09-12 | Astra Ab | NOVEL MEDICAL USE |
-
1997
- 1997-12-05 EP EP97952292A patent/EP0946192A1/en not_active Withdrawn
- 1997-12-05 WO PCT/US1997/022292 patent/WO1998024472A1/en not_active Application Discontinuation
- 1997-12-05 CA CA002274116A patent/CA2274116C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2274116C (en) | 2009-05-05 |
WO1998024472A1 (en) | 1998-06-11 |
EP0946192A1 (en) | 1999-10-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU3313589A (en) | 17beta-n-monosubstituted carbamoyl or 17beta-acyl-4-aza- 5alpha-androst-1-en-3-ones as 5alpha reductase inhibitors | |
HU9401679D0 (en) | Alpha-heteroaryloxymethyl-ketones as interleukin-1-beta converting enzyme inhibitors | |
IL108075A0 (en) | Enzyme inhibitors | |
AU5533094A (en) | Enzyme inhibitors | |
AU1301295A (en) | Biocidal compositions and methods for treating commercial and recreational water | |
AU2582897A (en) | Compositions and methods for the diagnosis, prevention, and treatment of neoplastic cell growth and proliferation | |
AU6097094A (en) | Antisense polynucleotide inhibition of human growth factor-sensitive cancer cells | |
AU3901985A (en) | Erythorbates as corrosion inhibitor in brine | |
EP0583074A3 (en) | Angiotensin converting enzyme inhibitor and method for preparing same. | |
HK1020334A1 (en) | Potassium channel inhibitors | |
NZ324921A (en) | Cathepsin K crystal structure and methods of identifying inhibitors of this protease | |
AP9901674A0 (en) | Method of using cyclooxygenase-2 inhibitors in the prevention of cardiovascular disorders. | |
AU3634695A (en) | Surface active agents as gas hydrate inhibitors | |
AU3943793A (en) | Methods of inhibiting or enhancing scar formation in the CNS | |
EP0670727A4 (en) | Compounds that inhibit t cell proliferation and methods using the same. | |
AU5597098A (en) | Inhibitors of the enzymatic activity of psa | |
AU3769097A (en) | Substituted bisindolylmaleimides for the inhibition of cell proliferation | |
EP0220107A3 (en) | Use of angiotensin-converting enzyme inhibitors in macular degeneration | |
HK1033096A1 (en) | Combination of hypertensin converting enzyme inhibitor with a diuretic for treating microcirculationdisorders | |
GB9315846D0 (en) | Tumour inhibitors | |
AU6090594A (en) | Angiotensin ii inhibitors | |
AU613302B2 (en) | Quinolyloxazole-2-ones useful as proteinkinase c inhibitors | |
CA2158609A1 (en) | 5 .alpha.-reductase inhibitors | |
EP0599514A3 (en) | Pyranoquinoline derivatives as inhibitors of cell proliferation. | |
EP0858262A4 (en) | Thrombin inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |